IAIM-AMR
Volume 1 | Issue 2 | 2025 Pages 1-17

Guidelines for the clinical diagnosis and treatment of retinoblastoma (2025)

Yi Shao, JianMin Ma,Xiaoming Huang

Received: November 24, 2024 Accepted: December 19, 2024 Published: May 20, 2025

ABSTRACT

Retinoblastoma (RB) is the most common intraocular malignant tumor in children under five , which compromises the visual function and life of children. Since most RB patients have reached the extraocular stage at the time of initial diagnosis, the mortality rate remains high, which brings great challenges to clinical treatment. Therefore, early diagnosis and standardized treatment are of great significance for RB. To this end, the Ophthalmology Committee of the Ophthalmology Branch of the Chinese Medical Doctor Association, the Ophthalmology Committee of the International Intelligent Medical Association and the Ophthalmology Committee of the International Association of Translational Medicine presided over the formulation of the clinical diagnosis and treatment guidelines for retinoblastoma, which gave a detailed introduction to the etiology, diagnosis, staging and treatment of RB, aiming to help clinicians improve the diagnostic efficiency and formulate diagnosis and treatment plans for patients more quickly and effectively.